Hikal Ltd.

NSE: HIKAL | BSE: 524735 | ISIN: INE475B01022 | Industry: Pharmaceuticals
| Expensive Star

logo
Hikal Ltd.
13 May 2019
410.95
-3.45%
BP Wealth
in gross margin due to change in product mix, EBITDA margin manage to remain at 18.4% level, was 121bps lower than our estimate. Adj. PAT came above our estimate at INR333mn (est INR298mn) Sector Outlook supported by lower tax expense (30.8% vs 35.3%) and decline in interest cost....
Hikal Ltd. has an average target of 420.00 from 1 broker.
More from Hikal Ltd.
Recommended